Deal Snapshot
4D Pharma Files SEC Forms in Process to Gain NASDAQ Listing Following Merger with Longevity
Monday 30 November 2020

UK-based pharmaceutical company 4D pharma plc (AIM: DDDD) has filed a registration statement on form F-4 with the US Securities and Exchange Commission, the company said.

The filing follows the announcement on October 22, 2020 of the proposed merger between 4D pharma and Longevity acquisition Corp. (NASDAQ: LOAC), a NASDAQ-listed Special Purpose acquisition company.

Date Published: 30/11/2020